Good morning
News Headline from Leading Financial News Papers, Compiled by 𝐑𝐔𝐃𝐑𝐀 𝐒𝐇𝐀𝐑𝐄𝐒
Wednesday, 09 April, 2025
* Regulatory easing to support 10.8 pc credit growth in FY26: Icra
* Adani Wilmar to be renamed AWL Agri Business from April 16
* Bandhan Bank launches savings account for HNIs
* JLR evaluating various steps to respond to US tariffs: Tata Motors
* Cricket fever fuels surge in pay-TV subscriber base
* Railways draws up new PPP policy
* India's anti-obesity drug market has grown more than fourfold in the last five years
* Globalstar, Apple's satcom partner, joins the race to enter India's space communications market
* PVR Inox partners with Visa to enable mobile tap-to-pay transactions
* No revenue loss from infra sharing with Reliance Jio: BSNL
* India open to zero duty on imports from US in PLI, some other sectors
* Trump announces plan for ‘major’ tariff on pharmaceutical imports
* M&M shares gain as it incorporates arm Mahindra Advanced Technologies
* HUDCO to provide up to Rs 1.5 lakh crore funds for MMRDA's infra projects over 5 years, shares rise
* Given the increased uncertainty, we are not looking to make aggressive deployment decisions: Axis AMC’s Ashish Gupta
* 'Cyient announces launch of semiconductor subsidiary, shares rise
* boAt files draft papers via confidential pre-filing route for Rs 2,000-cr IPO
* Jio Financial shares rise as top Nifty gainer on foray into loans against securities
* Shriram Finance, Cholamandalam, other BFSI stocks gain on hopes of RBI rate cut
* 'NSE, BSE to observe 3 holidays in April starting this week with Mahavir Jayanti
* Trump tariffs a 'multi-fold geopolitical risk' for world economy, says ABSL AMC's Mahesh Patil
* FIIs sell Rs 4,994 crore worth of shares; DIIs buy Rs 3,097 crore on April 8
* "Bulk & Block deals: Tata Mutual Fund offloads 0.53% equity in Sonata Software
* Another 5-10% correction quite possible if uncertainty persists and situation in US turns more stagflationary, says TRUST MF's Sandeep Bagla
* Apple mulls more India-made iPhones for US to avoid China tariffs: Report
* ‘Natco Pharma aims to launch generic of Roche’s rare disease drug after favourable ruling in patent infringement case
For more details-